Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -28,897 | -65,535 | -30,487 |
| Depreciation Amortization | 20,744 | 23,022 | 367 |
| Income taxes - deferred | -1,576 | N/A | N/A |
| Accounts receivable | -4,792 | N/A | N/A |
| Accounts payable and accrued liabilities | 9,416 | N/A | N/A |
| Other Working Capital | 1,401 | -11,883 | 1,438 |
| Other Operating Activity | 9,891 | 16,899 | 13,228 |
| Operating Cash Flow | $6,187 | $-37,497 | $-15,454 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -79 | -578 | -80 |
| Net Acquisitions | N/A | 24,985 | 0 |
| Other Investing Activity | 66 | 18 | -149 |
| Investing Cash Flow | $-13 | $24,425 | $-229 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -1,506 | 65,942 | 3,265 |
| Financing Cash Flow | $-1,506 | $65,942 | $3,265 |
| Exchange Rate Effect | -3,830 | 3,133 | -767 |
| Beginning Cash Position | 67,229 | 11,226 | 24,411 |
| End Cash Position | 68,067 | 67,229 | 11,226 |
| Net Cash Flow | $838 | $56,003 | $-13,185 |
| Free Cash Flow | |||
| Operating Cash Flow | 6,187 | -37,497 | -15,454 |
| Capital Expenditure | -79 | N/A | N/A |
| Free Cash Flow | 6,108 | -37,497 | -15,454 |